Abstract |
Two eight-step pathways for synthesizing the stereoisomeric compounds (-)-2-[1-(2,6-dichlorophenoxy)ethyl]-2- imidazoline hydrochloride ("levlofexidine" hydrochloride; (-)- lofexidine hydrochloride) and (+)-2-[1-(2,6-dichlorophenoxy)ethyl]-2- imidazoline hydrochloride ("dexlofexidine" hydrochloride; (+)- lofexidine hydrochloride) and the optical resolution of (+/-)- lofexidine are described. (-)- Lofexidine, a stereoselective alpha 2-adrenoceptor agonist, due to its center of asymmetry, is demonstrated to be a potent drug for the treatment of hypertension (doses 0.561 microgram/kg) and to have the highest affinity and a concentration dependency for alpha 2-adrenoceptors in direct binding studies (0.36 nmol/L). (+)- Lofexidine is 10 times less potent.
|
Authors | J Biedermann, A León-Lomelí, H O Borbe, G Prop |
Journal | Journal of medicinal chemistry
(J Med Chem)
Vol. 29
Issue 7
Pg. 1183-8
(Jul 1986)
ISSN: 0022-2623 [Print] United States |
PMID | 2879913
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- Adrenergic alpha-Agonists
- Imidazoles
- Indicators and Reagents
- Receptors, Adrenergic, alpha
- Clonidine
- lofexidine
|
Topics |
- Adrenergic alpha-Agonists
(chemical synthesis)
- Animals
- Blood Pressure
(drug effects)
- Brain
(metabolism)
- Clonidine
(analogs & derivatives, chemical synthesis, pharmacology)
- Drug Evaluation, Preclinical
- Imidazoles
(chemical synthesis, pharmacology)
- Indicators and Reagents
- Male
- Optical Rotation
- Rats
- Rats, Inbred Strains
- Receptors, Adrenergic, alpha
(drug effects, metabolism)
- Stereoisomerism
- Structure-Activity Relationship
|